Correlation between circulating adhesion molecules and resistin levels in hypertensive type-2 diabetic patients

Inflammation and Allergy - Drug Targets

Volumn 10, Issue 1, 2011, Pages 27-31

  Lozano Nuevo, José Juan ^a,b   Estrada Garcia, Teresa ^b   Vargas Robles, Hilda ^b   Escalante Acosta, Bruno A ^b   Rubio Guerra, Alberto F ^a  

^a Hospital General de Ticoman SS DF   (Mexico)

^b INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

Author keywords

Circulating adhesion molecules; Hypertension; Inflammation; Resistin; Type 2 diabetes mellitus

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; RESISTIN; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ARTICLE; BLOOD VESSEL INJURY; CLINICAL ARTICLE; DIABETIC PATIENT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPERTENSION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PROTEIN DETERMINATION;

EID: 79551637846     PISSN: 18715281     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152811794352024     Document Type: Article

References (20)

1. Afsar, B.; Sezer, S.; Elsurer, R.; Ozdemir, F.N. Is HOMA index a predictor of nocturnal nondipping in hypertensives with newly diagnosed type 2 diabetes mellitus? Blood Press. Monit., 2008, 13(1), 63-64.
2. Rubio, A.F.; Vargas, H.; Lozano, J.J. Escalante BA. Corrrelation between circulating adhesión molecules levels and albuminuria in type 2 diabetic hypertensive patients. Kidney Blood Press. Res., 2009, 32(4), 106-109.
3. Woolard, K.J.; Chin-Dusting, J. Therapeutic targeting of P-selectin in atherosclerosis. Inflamm. Allergy-Drug Targets, 2006, 6, 69-74.
4. Rizzoni, D.; Muiesan, M.L.; Porteri, E.; Castellano, M.; Salvetti, M.; Monteduro, C.; De Ciuceis, C.; Boari, G.; Valentini, U.; Cimino, A.; Sleiman, I.; Agabiti-Rosei, E. Circulating adhesion molecules and carotid artery structural changes in patients with non-insulin-dependent diabetes mellitus. J. Hum. Hypertens., 2003, 17(7), 463-470.
5. Mallika, V.; Goswami, B.; Rajappa, M. Atherosclerosis pathophysiology and the role of novel risk factors: A clinicobiochemical perspective. Angiology, 2007, 58(5), 513-522.
6. Hansson, G.K. Inflammation, atherosclerosis and coronary artery disease. N. Engl. J. Med., 2005, 352(16), 1685-1695.
7. Tokuyama, Y.; Osawa, H.; Ishizuka, T.; Onuma, H.; Matsui, K.; Egashira, T.; Makino, H.; Kanatsuka, A. Serum resistin level is associated with insulin sensitivity in Japanese patients with type 2 diabetes mellitus. Metabolism, 2007, 56(5), 693-698.
8. Libby, P.; Ridker, P.M.; Maseri, A. Inflammation and atherosclerosis. Circulation, 2002, 105(9), 1135-1143
9. Qatani, M.; Szwergold, N.R.; Greaves D.R.; Ahima, R.S.; Lazar, M.A. Macrophage-derived human resistin exacerbates adipose tissue inflammation and insulin resistance in mice. J. Clin. Invest., 2009, 119, 531-539.
10. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care, 2006, 29(Suppl. 1), S43-S48.
11. The seven report of the joint national committee on detection, evaluation, and treatment of high blood pressure. JNC 7. Complete version. Hypertension, 2003, 42, 1206-1252.
12. Shety, G.K.; Economides, P.A.; Horton, E.S.; Mantzoros, Cs.; Veves, A. Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers and vascular reactivity in diabetic patients and subjects at risk for diabetes. Diabetes Care, 2004, 27(10), 2450-2457.
13. Ghittoni, R.; Lazzerini, P.E.; Pasini, F.L.; Baldari, C.T. T lymphocytes as targets of statins: Molecular mechanisms and therapeutic perspectives. Inflamm. Allergy-Drug Targets, 2006, 6(1), 3-16.
14. Gasic, S.; Wagner, O.; Fasching, P.; Ludwig, C.; Veitl, M.; Kapiotis, S.; Jilma, B. Fosinopril decreases levels of soluble vascular cell adhesion molecule-1 in borderline hypertensive type-2 diabetic patients with microalbuminuria. Am. J. Hypertens., 1999, 12(2 Pt. 1), 217-222.
15. Zanchetti, A.; Bond, M.G.; Hennig, M.; Neiss, A.; Mancia, G.; Dal Palù, C.; Hansson, L.; Magnani, B.; Rahn, K.H.; Reid, J.L.; Rodicio, J.; Safar, M.; Eckes, L.; Rizzini, P.; European Lacidipine Study on Atherosclerosis investigators. Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis. Circulation, 2002, 106(19), 2422-2427.
16. Yamaguchi, M.; Suwa, H.; Miyasaka, M.; Kumada, K. Selective inhibition of vascular cell adhesion molecule-1 expression by verapamil in human vascular endothelial cells. Transplantation, 1997, 63(5), 759-764.
17. Rubio-Guerra, A.F.; Vargas-Robles, H.; Vargas-Ayala, G.; Rodriguez-Lopez, L.; Escalante-Acosta, B.A. The effect of trandolapril and its fixed-dose combination with verapamil on circulating adhesion molecules levels in hypertensive patients with type 2 diabetes. Clin. Exp. Hypertens., 2008, 30(7), 682-688.
18. Steppan, C.M.; Bailey, S.T.; Bhat, S.; Brown, E.J.; Banerjee, R.R.; Wright, C.M.; Patel, H.R.; Ahima, R.S.; Lazar, M.A. The hormone resistin links obesity to diabetes. Nature, 2001, 409(6818), 307-312
19. Kim, J.; Montagnani, M.; Koh, K.K.; Quon, M.J. Reciprocal relationship between insulin resistance and endothelial dysfunction. Circulation, 2006, 113(15), 1888-1904.
20. Rubio, A.F.; Vargas, H.; Maceda, A.; Vargas, G.; Rodriguez, L.; Escalante, B.A. Correlation between the levels of circulating adhesion molecules and atherosclerosis in hypertensive type-2 diabetic patients. Clin. Exp. Hypertens., 2010, 32(5), 308-310.